Rapid Influenza Diagnostic Tests Market Trends, Active Key Players and Growth Projection Up to 2031|Thermo Fisher Scientific, Hologic

Rapid Influenza Diagnostic Tests Market 2022-2031

The Rapid Influenza Diagnostic Tests Market is slated to grow unstoppably in the years to come. The healthcare providers are, of late, making way for more specialized and timely treatment through same-day surgeries, outpatient surgeries, and likewise. ASCs (Ambulatory Surgical Centers) are preferred over conventional hospital settings. As such, cost-effective medical services could be provided. This type of customization is expected to take the healthcare vertical by storm in the future.

As per Persistence Market Research's latest revised industry analysis, the global rapid influenza diagnostic tests market is expected to witness high growth during the forecast period. The market is expected to top US$ 2 Bn by 2031, which reflects a CAGR of around 8.7% for the decade.

Request for Free Sample Report of "Rapid Influenza Diagnostic Tests" Market @ https://www.persistencemarketresearch.com/samples/31040

Influenza is recognized as a major source of illness and mortality in humans, prompting the development and implementation of diagnostics aimed at decreasing the health and economic consequences. Influenza causes serious illness or death, primarily in high-risk people.

With the start of the flu season comes an increase in antibiotic use, elevating the danger of antibiotic resistance in the body. The speedy turn-around times of devices used at point-of-care aid in the preparation of a targeted and successful treatment plan based on test results. Rapid influenza diagnostic tests have a short turnaround time, with some offering results in under 15 minutes. As a result, adoption of rapid influenza diagnostic tests helps prevent over-prescription of antibiotics as well as avoid the core cause of bacterial resistance and its negative consequences.

Key Players:

The report has profiled some of the important players prevalent in the global like - Thermo Fisher Scientific, Hologic, Quidel Corporation, F. Hoffmann-La Roche AG, Abbott Laboratories, Becton Dickinson and Company, Danaher Corporation, Meridian Bioscience, bioMérieux SA, Luminex Corporation, Siemens Healthineers AG, GenMark Diagnostics, Sekisui Diagnostics, LLC altona Diagnostics GmbH, SA Scientific, and ELITech Group and more.

This report covers the sales volume, price, revenue, gross margin, manufacturers, suppliers, distributors, intermediaries, customers, historical growth and future perspectives in the Rapid Influenza Diagnostic Tests Market.     

The current COVID-19 pandemic has also boosted demand for rapid influenza diagnostic tests. When compared to influenza, COVID-19 has a similar illness presentation - both viruses induce respiratory problems. Furthermore, both are spread via touch, droplets, and fomites. COVID-19 patients have been misdiagnosed with influenza in the past, which has increased demand for virus rapid detection kits.

Emergence of smartphone-based disease screening has increased market revenue. The Human Genome Project and breakthroughs in molecular and biomedical technology have led to the creation of a plethora of assays and technologies useful for the diagnosis and monitoring of influenza infections. These new technologies, which are based on genomic (PCR-based) and proteomic (microarray-based detection) techniques, aid in the discovery of novel influenza viruses. They also allow for improved surveillance and rapid detection of infectious diseases, which presents a good business opportunity for market players.

Key Takeaways from Market Study

By principle, immunochromatographic assays are set hold high share of 66.8% in 2021, expanding at 6.1% CAGR over the forecast period.

By test type, influenza A+B test is expected to hold 79% market share, and is expected to continue growing at similar trend due to its benefits such as simple to use and rapid diagnosis.

By sample, the nasopharyngeal swab segment is expected to 31% market share, and nasopharyngeal aspirate is the second-leading segment, which accounts for 27.5%.

By end user, office-based settings account for nearly 22.5% market share.

By region, North America held 36.6% of the global market share in 2021.

"Rising demand for rapid disease diagnosis, increasing influenza prevalence, and increased research for diagnostic technologies are expected to provide growth opportunities for market players," says an analyst of Persistence Market Research.

Market Competition

Leading market players are focusing on product approvals and launches as a key growth strategy for global expansion, thereby enhancing their market presence. They are also emphasizing on entering into strategic partnerships with local suppliers and distributors to expand product reach.

In March 2021, Abbott received an Emergency Use Authorization (EUA) from the US Food and Drug Administration (FDA) for its AlinityTM m Resp-4-Plex molecular assay, which can identify and discriminate SARS-CoV-2, influenza A, influenza B, and respiratory syncytial virus (RSV) all in one test. This test has received CE certification and is available in countries other than the United States.

In February 2020, the FDA granted Quidel an Emergency Use Authorization (EUA) to market its Sofia® 2 Flu + SARS Antigen FIA for the rapid, simultaneous qualitative identification, and characterization of nucleocapsid protein antigens from SARS-CoV-2, influenza A, and influenza B in direct nasopharyngeal (NP) and nasal (NS) swab samples from persons suspected of respiratory viral infection consistent with COVID-19.

In August 2017, Meridian Bioscience, Inc. announced the expansion of its ImmunoCard STAT!® product line with the addition of ImmunoCard STAT! FLU A&B.

Request For Customization @ https://www.persistencemarketresearch.com/request-customization/31040

Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Araia, South Africa etc.)

Key Stakeholders 
Rapid Influenza Diagnostic Tests Market Manufacturers 
Rapid Influenza Diagnostic Tests Market Distributors/Traders/Wholesalers 
Rapid Influenza Diagnostic Tests Market Subcomponent Manufacturers 
Industry Association 
Downstream Vendors

If you have any special requirements, please let us know and we will offer you the report as you want. 

Key Questions Answered in the Rapid Influenza Diagnostic Tests Market Report

How is the Rapid Influenza Diagnostic Tests Market expected to grow over the projected period?

What direction is the Rapid Influenza Diagnostic Tests Market expected to take in terms of volume and value during the forecast period?

What is the impact of macroeconomic factors on the Rapid Influenza Diagnostic Tests Market in future?

What are the key market drivers in the Rapid Influenza Diagnostic Tests Market?

What are significant opportunities and improvement areas for Rapid Influenza Diagnostic Tests Market manufacturers?

What are the key developments and trends taking over the Rapid Influenza Diagnostic Tests Market?

Which are the emerging countries that are expected to create significant growth opportunities in the Rapid Influenza Diagnostic Tests Market?  

If you have any special requirements, please let us know and we will offer you the report as you want and also We Provide you Table of Content.

Click Here to Get this Report@ https://www.persistencemarketresearch.com/checkout/31040

Media Contact:

Persistence Market Research

305 Broadway,7th Floor New York City, NY 10007 United States

Call +1-646-568-7751

Call +1 800-961-0353

sales@persistencemarketresearch.com

About PersistenceMarketResearch:

PersistenceMarketResearch is an esteemed company with a reputation of serving clients across domains of information technology (IT), healthcare, and chemicals. Our analysts undertake painstaking primary and secondary research to provide a seamless report with a 360 degree perspective. Data is compared against rep/uted organizations, trustworthy databases, and international surveys for producing impeccable reports backed with graphical and statistical information.

This release was published on openPR.